Ovid Therapeutics
OVID
#7730
Rank
โ‚ฌ0.37 B
Marketcap
2,01ย โ‚ฌ
Share price
-5.98%
Change (1 day)
64.98%
Change (1 year)

Earnings for Ovid Therapeutics (OVID)

Earnings in 2026 (TTM): -โ‚ฌ29.97 Million

According to Ovid Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ1.58 Million. In 2025 the company made an earning of -โ‚ฌ15.88 Million, an increase over its 2024 earnings that were of -โ‚ฌ24.1 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Ovid Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ29.97 Million88.74%
2025 -โ‚ฌ15.88 Million-34.12%
2024 -โ‚ฌ24.1 Million-49.5%
2023 -โ‚ฌ47.72 Million-3.29%
2022 -โ‚ฌ49.34 Million-143.59%
2021 โ‚ฌ0.11 B-253.22%
2020 -โ‚ฌ73.88 Million34.03%
2019 -โ‚ฌ55.12 Million16.32%
2018 -โ‚ฌ47.39 Million-19.79%
2017 -โ‚ฌ59.08 Million189.13%
2016 -โ‚ฌ20.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 352.68%๐Ÿ‡บ๐Ÿ‡ธ USA